For 21 days, a team of scientists at Wake Forest Baptist Medical Center monitored the effects of manufactured insulin on 60 adults with either mild cognitive impairment (MCI) or moderate Alzheimer's dementia (AD). One group was given 40 units of the nasal insulin detemir, another was given 20 units and a third group was given a placebo.
Of the three groups, short-term ability to process verbal and visual cues increased the most in those who were given 40 units of the spray. That same dosage of the spray was also able to increase memory scores for those carrying the gene that increases a person's risk for dementia the most. Carrying that particular gene usually makes the body resistant to most treatments.'
I already forgot what the article is about.